Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate

Journal of Andrology

Volumn 22, Issue 3, 2001, Pages 432-443

  Ravindranath, N ^a   Wion, D ^b   Brachet, P ^b   Djakiew, D ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b INSERM   (France)

Author keywords

Angiogenesis; Benign prostatic hyperplasia; Carcinoma; Epidermal growth factor; Prostate; Receptor; Vascular endothelial growth factor

Indexed keywords

EPIDERMAL GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL GROWTH; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROSTATE; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; TRANSURETHRAL RESECTION;

CARCINOMA; ENDOTHELIAL GROWTH FACTORS; EPIDERMAL GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MALE; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; REFERENCE VALUES; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035045386     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. RFLP for the human transforming growth factor beta-1 gene (TGFB) on chromosome 19
2. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA
3. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
4. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms
5. Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo
6. Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity
7. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation
8. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer
9. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract
10. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas
11. Human prostate cancer model: Roles of growth factors and extracellular matrices
12. Expression of transforming growth factor-alpha and the epidermal growth factor receptor in human prostatic tissue
13. VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells
14. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis
15. Secretion of epidermal growth factor and related polypeptides by the DU145 human prostate cell line
16. Production of epidermal growth factor and transforming growth factor-alpha by the androgen-responsive LNCaP human prostate cancer cell line
17. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: Rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth
18. Characterization of nerve growth factor precursor protein expression by human prostate stromal cells: A role in selective neurotrophin stimulation of prostate epithelial cell growth
19. Regulation of growth by a nerve growth factor-like protein which modulates paracrine interactions between a neoplastic epithelial cell line and stromal cells of the human prostate
20. Dysregulated expression of growth factors and their receptors in the development of prostate cancer
21. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
22. Role of vascular endothelial growth factor in the regulation of angiogenesis
23. Vascular endothelial growth factor (VEGF) expression in human prostate cancer: In situ and in vitro expression of VEGF by human prostate cancer cells
24. Expression of vascular endothelial growth factor receptors in human prostate cancer
25. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells
26. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia
27. Angiogenesis in cancer, vascular, rheumatoid and other disease
28. Angiogenesis
29. Epidermal growth factor receptor monoclonal antibody inhibits constitutive receptor phosphorylation, reduces autonomous growth, and sensitizes androgen-independent prostatic carcinoma cells to tumor necrosis factor alpha
30. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family
31. Receptors for factors of the VEGF
32. Epidermal growth factor and prostatic carcinoma: An immunohistochemical study
33. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing
34. Vascular endothelial growth factors and angiogenesis
35. Chromosomal localization of FLT4, a novel receptor-type tyrosine kinase gene
36. VEGF is required for growth and survival in neonatal mice
37. Comparative analysis of mRNA and protein expression for epidermal growth factor receptor and ligands relative to the proliferative index in human prostate tissue
38. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: A model of glioblastoma multiforme pathophysiology
39. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma
40. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
41. An immunochemical analysis of TGF-alpha expression in benign and malignant prostate
42. Expression of androgen receptor and growth factors in premalignant lesions of the prostate
43. Autonomous growth of androgen-independent human prostatic carcinoma cells: Role of transforming growth factor alpha
44. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA
45. Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia
46. Effect of epidermal growth factor on prostate cancer cell line PC3 growth and invasion
47. Comparative studies of the mitogenic effects of epidermal growth factor and transforming growth factor-alpha and the expression of various growth factors in neoplastic and non-neoplastic prostatic cell lines
48. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers
49. A role for phospholipase C-gamma-mediated signaling in tumor cell invasion
50. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
51. Vascular endothelial growth factor is a secreted angiogenic mitogen
52. Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF
53. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
54. Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: Evidence for a role of EGFR in breast cancer growth and progression
55. Vascular endothelial growth factor (VEGF) and its receptors
56. Vascular permeability factor gene expression in normal and neoplastic human ovaries
57. Signaling via vascular endothelial growth factor receptors
58. Expression of p75NTR in a human prostate epithelial tumor cell line reduces nerve growth factor-induced cell growth by activation of programmed cell death
59. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix
60. Epidermal growth factor (EGF) promotes chemomigration of a human prostate tumor cell line, and EGF immunoreactive proteins are present at sites of metastasis in the stroma of lymph nodes and medullary bone
61. Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary
62. Mechanisms of angiogenesis
63. Growth factor involvement in progression of prostate cancer. Growth factor involvement in progression of prostate cancer
64. Structure and function of vascular endothelial growth factor receptor-1 and -2
65. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family
66. Heparin affinity: Purification of a tumor-derived capillary endothelial cell growth factor
67. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
68. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma
69. Endogenous secretion of epidermal growth factor peptides stimulates growth of DU145 prostate cancer cells
70. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
71. Differential control of VEGF synthesis and secretion in human glioma cells by IL-1 and EGE
72. Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro
73. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma
74. Role of transforming growth factor-alpha in human prostate cancer cell growth
75. Epidermal growth factor and transforming growth factor alpha concentrations in BPH and cancer of the prostate: Their relationship with tissue androgen levels
76. Inhibition of chemomigration of a human prostatic carcinoma cell (TSU-pr1) line by inhibition of epidermal growth factor receptor function